Not Yet Recruiting PHASE2 INTERVENTIONAL 3-arm
NCT06617182
Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.
Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury: a Single-center, Open-label, Randomized Controlled Study
Sponsor: Yongquan Shi
Conditions
Radiation Enteritis
Interventions
Glutamine Thalidomide Thalidomide+Glutamine
Updated 1 time since 2024 Last updated: Sep 26, 2024 Started: Sep 30, 2024 Primary completion: Oct 1, 2025 Completion: Oct 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on Radiation Enteritis, this trial is actively recruiting participants. The trial is conducted by Yongquan Shi and has accumulated 1 data snapshot since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Yongquan Shi
Data source: Xijing Hospital of Digestive Diseases
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.